Table 2 Distribution of studied patients according to their BCS eligibility and final surgical decisions
From: Neoadjuvant chemotherapy for stage II–III breast cancer: a single-center experience
Total (n = 147) | Remained BCS | Converted to BCS | Converted to mastectomy | |
|---|---|---|---|---|
BCS candidate pre-chemotherapy | 66 (44.9%) | 58 (87.9%) | – | 8 (12.1%) |
BCS ineligible before chemotherapy | 81 (55.1%) | – | 40 (49.4%) | 41 (50.6%) |
Final surgery decision | ||||
- BCS | 98 (66.7%) | 72 (73.5%) | – | 26 (26.5%) |
- MRM | 49 (33.3%) | – | – | – |